|
NR 4-6/2007
|
|
|
|
|
|
|
|
|
Zastosowanie
iniekcji octanu triamcinolonu w leczeniu torbielowatego obrzęku
plamki w przebiegu zakrzepu żyły środkowej siatkówki
Inhtravitreal triamcinolone
acetonide injections in the treatment of cystoid macular edema
due to the central or branch retinal vein occlusion
Anna Lubczyńska, Jarosław Kocięcki
Z Katedry i Kliniki Okulistyki Akademii Medycznej w Poznaniu
Kierownik: dr hab. n. med. Jarosław Kocięcki |
|
|
| Summary: |
Purpose: To appoint the
most adequate follow-up parameter and to find the most
reliable scheme of intravitreal TA injections in CME
treatment in the course of CRVO and BRVO.
Material and methods: 18 eyes treated with intravitreal
injection of 4 mg (in 0.1 ml) of crystalline TA.
Results: There was improvement of BCVA for distance
noticed in 38.9% of eyes and for near in 44.4% of cases.
There was statistically significant difference in
retinal thickness outcomes measured at baseline and at
the end of the follow-up by both OCT and RTA. No
correlation of BCVA changes and retinal thickness
changes measured in OCT and RTA was found.
Conclusions: The intravitreal TA injections should be
considered as an effective method. Foveal morphology and
thickness analysis performed by OCT is the most adequate
method in follow-up monitoring of intravitreal TA
injections in CME treatment in non-ischemic CRVO or BRVO.
Central retinal thickness measured by RTA and FA changes
analysis are alternative monitoring methods. Dosage of
4mg TA in 0.1 ml seems to be sufficient. In cases of CME
recurrence of subsequent intravitreal injection in the
first 6 month after initial injection seems to be
unnecessary. |
| Słowa kluczowe: |
zakrzep żyły środkowej
siatkówki, zakrzep gałęzi żyły środkowej siatkówki,
torbielowaty obrzęk plamki, octan triamcinolonu. |
| Key words: |
central retinal vein
occlusion, branch retinal vein occlusion, cystoid macula
edema, triamcinolone acetonide. |
|
|
|
|
|
|
